I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 522.3 ILS 2.94% Market Closed
Market Cap: 251.2m ILS
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Accounts Receivables Peer Comparison

Comparables:
TEVA
SLGL
MDWD
S
SEMG
R
REKA

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
TASE:INCR
Accounts Receivables
â‚Ş201.5m
CAGR 3-Years
132%
CAGR 5-Years
N/A
CAGR 10-Years
76%
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Accounts Receivables
$3.8B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Accounts Receivables
$6.1m
CAGR 3-Years
85%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Accounts Receivables
$2.9m
CAGR 3-Years
0%
CAGR 5-Years
39%
CAGR 10-Years
76%
S
Seach Medical Group Ltd
TASE:SEMG
Accounts Receivables
â‚Ş26m
CAGR 3-Years
41%
CAGR 5-Years
59%
CAGR 10-Years
55%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Accounts Receivables
â‚Ş114.8m
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
1%

See Also

What is InterCure Ltd's Accounts Receivables?
Accounts Receivables
201.5m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Accounts Receivables amounts to 201.5m ILS.

What is InterCure Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
76%

Over the last year, the Accounts Receivables growth was 50%. The average annual Accounts Receivables growth rates for InterCure Ltd have been 132% over the past three years , and 76% over the past ten years .

Back to Top